annb0t
Top 20
MELBOURNE, Australia and INDIANAPOLIS, Jan. 31, 2025 /PRNewswire/ --Â Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition from antibody engineering company ImaginAb, Inc. (ImaginAb). The acquisition includes a pipeline of next-generation therapeutic candidates, a proprietary novel biologics technology platform, and a protein engineering and discovery research facility to enhance existing innovation capabilities[1].(PRNewsfo...
>>> Read more: Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
>>> Read more: Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
